Effective dose of IV dexmedetomidine for prolonging the duration of analgesia after single-shot femoral nerve block with ropivacaine for knee surgery
Not Applicable
Completed
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Registration Number
- KCT0002210
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 68
Inclusion Criteria
Unilateral surgical femoral nerve block procedures under general anesthesia
-American Society of Anesthesiologist classification I-III patients
-Age>18years
Exclusion Criteria
-American society of anesthesiologist classification IV or V patients
-Age<18years - pregnancy -coagulopathy -unstable coronary artery disease, congestive heart failure, arrythmia, cardiomyopathy -Known cerebrovascular disease -generalized infection, infection at skin femoral nerve block -chronic pain disorder -severe pulmonary neurologic deficits, neuropathy affecting limb -refusal -local anesthetics allery psychiatric>
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of interscalene nerve block
- Secondary Outcome Measures
Name Time Method opioid consumption ;pain score ;duration of motor blockade ;side effects to dexmedetomidine(bradycardia, temporary hypotension, sedation)